{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:19:15Z","timestamp":1787509155581,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jcrc.2019.04.029","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T13:40:49Z","timestamp":1556718049000},"page":"200-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Major publications in critical care pharmacotherapy literature in 2018"],"prefix":"10.1016","volume":"52","author":[{"given":"Andrea Sikora","family":"Newsome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany D.","family":"Bissell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Burry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrey A.","family":"Defayette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Joseph","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Semanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie N.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drayton A.","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcrc.2019.04.029_bb0005","doi-asserted-by":"crossref","first-page":"R258","DOI":"10.1186\/cc3514","article-title":"Worldwide research productivity in critical care medicine","volume":"9","author":"Michalopoulos","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2019.04.029_bb0010","author":"Berger"},{"issue":"3","key":"10.1016\/j.jcrc.2019.04.029_bb0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/CEH.0000000000000168","article-title":"A review of digital, social, and mobile technologies in health professional education","volume":"37","author":"Curran","year":"2017","journal-title":"J Contin Educ Health Prof"},{"issue":"4","key":"10.1016\/j.jcrc.2019.04.029_bb0020","first-page":"429","article-title":"How much effort is needed to keep up with the literature relevant for primary care","volume":"92","author":"Alper","year":"2004","journal-title":"J Med Libr Assoc"},{"issue":"7650","key":"10.1016\/j.jcrc.2019.04.029_bb0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.jcrc.2019.04.029_bb0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2146\/ajhp160144","article-title":"Major publications in the critical care pharmacotherapy literature in 2015","volume":"74","author":"Wong","year":"2017","journal-title":"Am J Health Syst Pharm"},{"issue":"22","key":"10.1016\/j.jcrc.2019.04.029_bb0035","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.2146\/ajhp150220","article-title":"Major publications in the critical care pharmacotherapy literature: January-December 2014","volume":"72","author":"Day","year":"2015","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.jcrc.2019.04.029_bb0040","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2146\/ajhp140241","article-title":"Major publications in the critical care pharmacotherapy literature: January-December 2013","volume":"72","author":"Rech","year":"2015","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.jcrc.2019.04.029_bb0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2146\/ajhp130303","article-title":"Major publications in the critical care pharmacotherapy literature: February 2012 through February 2013","volume":"71","author":"Turck","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jcrc.2019.04.029_bb0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcrc.2018.02.012","article-title":"Major publications in the critical care pharmacotherapy literature: January-December 2017","volume":"45","author":"Hammond","year":"2018","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2019.04.029_bb0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jcrc.2017.09.178","article-title":"Major publications in the critical care pharmacotherapy literature: January-December 2016","volume":"43","author":"Horner","year":"2018","journal-title":"J Crit Care"},{"issue":"9","key":"10.1016\/j.jcrc.2019.04.029_bb0060","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.jcrc.2019.04.029_bb0065","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/CCM.0000000000003152","article-title":"Early enteral nutrition provided within 24 hours of ICU admission: a meta-analysis of randomized controlled trials","volume":"46","author":"Tian","year":"2018","journal-title":"Crit Care Med"},{"issue":"10116","key":"10.1016\/j.jcrc.2019.04.029_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(17)32146-3","article-title":"Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2)","volume":"391","author":"Reignier","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jcrc.2019.04.029_bb0075","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jcrc.2019.04.029_bb0080","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/CCM.0000000000003262","article-title":"Corticosteroids in sepsis: an updated systematic review and meta-analysis","volume":"46","author":"Rochwerg","year":"2018","journal-title":"Crit Care Med"},{"issue":"17","key":"10.1016\/j.jcrc.2019.04.029_bb0085","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa1716405","article-title":"Tenecteplase versus alteplase before thrombectomy for ischemic stroke","volume":"378","author":"Campbell","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jcrc.2019.04.029_bb0090","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"Semler","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jcrc.2019.04.029_bb0095","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jcrc.2019.04.029_bb0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S2213-2600(18)30004-3","article-title":"Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trial","volume":"6","author":"Itenov","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.jcrc.2019.04.029_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcrc.2019.04.029_bb0110","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1056\/NEJMoa1808217","article-title":"Haloperidol and ziprasidone for treatment of delirium in critical illness","volume":"379","author":"Girard","year":"2018","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jcrc.2019.04.029_bb0115","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/jama.2018.0160","article-title":"Effect of haloperidol on survival among critically ill adults with a high risk of delirium: the REDUCE randomized clinical trial","volume":"319","author":"van den Boogaard","year":"2018","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jcrc.2019.04.029_bb0120","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jcrc.2019.04.029_bb0125","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/00003246-199509000-00021","article-title":"Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine","volume":"23","author":"Shapiro","year":"1995","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2019.04.029_bb0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00003246-200201000-00020","article-title":"Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult","volume":"30","author":"Jacobi","year":"2002","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2019.04.029_bb0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CCM.0b013e3182783b72","article-title":"Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit","volume":"41","author":"Barr","year":"2013","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.jcrc.2019.04.029_bb0140","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/CCM.0000000000003298","article-title":"Methodologic innovation in creating clinical practice guidelines: insights from the 2018 Society of Critical Care Medicine pain, agitation\/sedation, delirium, immobility, and sleep disruption guideline effort","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.jcrc.2019.04.029_bb0145","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/CCM.0000000000003307","article-title":"Interpreting and implementing the 2018 pain, agitation\/sedation, delirium, immobility, and sleep disruption clinical practice guideline","volume":"46","author":"Balas","year":"2018","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcrc.2019.04.029_bb0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0885066615620592","article-title":"Ketamine for analgosedation in the intensive care unit: a systematic review","volume":"32","author":"Patanwala","year":"2017","journal-title":"J Intensive Care Med"},{"issue":"6","key":"10.1016\/j.jcrc.2019.04.029_bb0155","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/bja\/aer083","article-title":"Pregabalin has an opioid-sparing effect in elderly patients after cardiac surgery: a randomized placebo-controlled trial","volume":"106","author":"Pesonen","year":"2011","journal-title":"Br J Anaesth"},{"issue":"10","key":"10.1016\/j.jcrc.2019.04.029_bb0160","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/phar.2017","article-title":"Repurposing valproate, enteral clonidine, and phenobarbital for comfort in adult ICU patients: a literature review with practical considerations","volume":"37","author":"Gagnon","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jcrc.2019.04.029_bb0165","article-title":"A pharmacy-based electronic handoff tool to reduce discharge prescribing of atypical antipsychotics initiated in the intensive care unit: a quality improvement initiative","volume":"897190018761412","author":"Kram","year":"2018","journal-title":"J Pharm Pract"},{"issue":"4","key":"10.1016\/j.jcrc.2019.04.029_bb0170","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/CCM.0000000000003633","article-title":"Evaluation of medication errors at the transition of care from an ICU to non-ICU location","volume":"47","author":"Tully","year":"2019","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcrc.2019.04.029_bb0175","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/CNQ.0000000000000172","article-title":"Oral agents for the management of agitation and agitated delirium in critically ill patients","volume":"40","author":"Yeo","year":"2017","journal-title":"Crit Care Nurs Q"},{"issue":"2","key":"10.1016\/j.jcrc.2019.04.029_bb0180","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jcrc.2019.04.029_bb0185","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jcrc.2019.04.029_bb0190","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2019.04.029_bb0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/CCM.0000000000002840","article-title":"Guidelines for the diagnosis and management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in critically ill patients (part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017","volume":"46","author":"Pastores","year":"2018","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.jcrc.2019.04.029_bb0200","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/CCM.0000000000002737","article-title":"Guidelines for the diagnosis and management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in critically ill patients (part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017","volume":"45","author":"Annane","year":"2017","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.jcrc.2019.04.029_bb0205","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/CCM.0000000000001670","article-title":"The fragility index in multicenter randomized controlled critical care trials","volume":"44","author":"Ridgeon","year":"2016","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.jcrc.2019.04.029_bb0210","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0000000000000318","article-title":"Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response","volume":"42","author":"Katsenos","year":"2014","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2019.04.029_bb0215","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/cc10601","article-title":"Early initiation of low-dose corticosteroid therapy in the management of septic shock: a retrospective observational study","volume":"16","author":"Park","year":"2012","journal-title":"Crit Care"},{"issue":"13","key":"10.1016\/j.jcrc.2019.04.029_bb0220","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1304623","article-title":"Nutrition in the acute phase of critical illness","volume":"370","author":"Casaer","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcrc.2019.04.029_bb0225","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/CCM.0000000000001525","article-title":"Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)","volume":"44","author":"Taylor","year":"2016","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2019.04.029_bb0230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clnu.2018.08.037","article-title":"ESPEN guideline on clinical nutrition in the intensive care unit","volume":"38","author":"Singer","year":"2019","journal-title":"Clin Nutr"},{"issue":"12","key":"10.1016\/j.jcrc.2019.04.029_bb0235","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s00134-009-1664-4","article-title":"Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials","volume":"35","author":"Doig","year":"2009","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2019.04.029_bb0240","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13054-016-1298-1","article-title":"Enteral versus parenteral nutrition in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Elke","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2019.04.029_bb0245","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13054-015-0902-0","article-title":"Effect of initial calorie intake via enteral nutrition in critical illness: a meta-analysis of randomised controlled trials","volume":"19","author":"Tian","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2019.04.029_bb0250","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/CEOR.S48821","article-title":"Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a full economic analysis of a multicenter randomized controlled trial based on US costs","volume":"5","author":"Doig","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.jcrc.2019.04.029_bb0255","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2147\/CEOR.S50722","article-title":"Early enteral nutrition in critical illness: a full economic analysis using US costs","volume":"5","author":"Doig","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"issue":"15","key":"10.1016\/j.jcrc.2019.04.029_bb0260","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2165\/00003088-200241150-00001","article-title":"Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction","volume":"41","author":"Tanswell","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"10.1016\/j.jcrc.2019.04.029_bb0265","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1161\/STROKEAHA.115.011290","article-title":"Coagulation and fibrinolytic activity of tenecteplase and alteplase in acute ischemic stroke","volume":"46","author":"Huang","year":"2015","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.jcrc.2019.04.029_bb0270","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1474-4422(17)30253-3","article-title":"Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial","volume":"16","author":"Logallo","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jcrc.2019.04.029_bb0275","unstructured":"Centre ANZCTRISNNCT. Identifier ACTRN12613000243718. Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE) trial https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12613000243718; 2013 [accessed 12\/18\/2018."},{"key":"10.1016\/j.jcrc.2019.04.029_bb0280","unstructured":"(US). CgIBMNLoM. Alteplase-tenecteplase trial evaluation for stroke thrombolysis (ATTEST2), https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02814409; 2000 [accessed 12\/18\/2018."},{"issue":"1","key":"10.1016\/j.jcrc.2019.04.029_bb0285","doi-asserted-by":"crossref","first-page":"G201","DOI":"10.1152\/ajpgi.00186.2006","article-title":"Hepatocyte NF-kappaB activation is hepatoprotective during ischemia-reperfusion injury and is augmented by ischemic hypothermia","volume":"292","author":"Kuboki","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"10.1016\/j.jcrc.2019.04.029_bb0290","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1164\/rccm.201110-1820OC","article-title":"Fever control using external cooling in septic shock: a randomized controlled trial","volume":"185","author":"Schortgen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2019.04.029_bb0295","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jss.2012.05.045","article-title":"Therapeutic hypothermia attenuates liver injury in polymicrobial sepsis model of rats via Akt survival pathway","volume":"181","author":"Lee","year":"2013","journal-title":"J Surg Res"},{"issue":"12","key":"10.1016\/j.jcrc.2019.04.029_bb0300","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1097\/CCM.0b013e31829791da","article-title":"Mild hypothermia attenuates circulatory and pulmonary dysfunction during experimental endotoxemia","volume":"41","author":"Schwarzl","year":"2013","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2019.04.029_bb0305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/CCM.0000000000003482","article-title":"Caring for critically ill patients with the ABCDEF bundle: results of the ICU liberation collaborative in over 15,000 adults","volume":"47","author":"Pun","year":"2019","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.jcrc.2019.04.029_bb0310","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1513\/AnnalsATS.201501-066OC","article-title":"ABCDE, but in that order? A cross-sectional survey of Michigan intensive care unit sedation, delirium, and early mobility practices","volume":"12","author":"Miller","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"10","key":"10.1016\/j.jcrc.2019.04.029_bb0315","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1164\/rccm.201607-1345OC","article-title":"Balanced crystalloids versus saline in the intensive care unit. The SALT randomized trial","volume":"195","author":"Semler","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"16","key":"10.1016\/j.jcrc.2019.04.029_bb0320","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.2015.12334","article-title":"Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial","volume":"314","author":"Young","year":"2015","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.jcrc.2019.04.029_bb0325","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2012.13356","article-title":"Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults","volume":"308","author":"Yunos","year":"2012","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jcrc.2019.04.029_bb0330","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/CCM.0000000000000305","article-title":"Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*","volume":"42","author":"Raghunathan","year":"2014","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.jcrc.2019.04.029_bb0335","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s00134-014-3505-3","article-title":"Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS","volume":"40","author":"Shaw","year":"2014","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.jcrc.2019.04.029_bb0340","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/SLA.0b013e31825074f5","article-title":"Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to plasma-Lyte","volume":"255","author":"Shaw","year":"2012","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.jcrc.2019.04.029_bb0345","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/CCM.0000000000001948","article-title":"Lactated ringer is associated with reduced mortality and less acute kidney injury in critically ill patients: a retrospective cohort analysis","volume":"44","author":"Zampieri","year":"2016","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.jcrc.2019.04.029_bb0350","first-page":"239","article-title":"The plasma-Lyte 148 v saline (PLUS) study protocol: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality","volume":"19","author":"Hammond","year":"2017","journal-title":"Crit Care Resusc"},{"issue":"3","key":"10.1016\/j.jcrc.2019.04.029_bb0355","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/CCM.0b013e3181ffe0eb","article-title":"Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study","volume":"39","author":"Levy","year":"2011","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcrc.2019.04.029_bb0360","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00134-018-5222-9","article-title":"Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients","volume":"44","author":"Leopold","year":"2018","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2019.04.029_bb0365","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13054-016-1387-1","article-title":"Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality","volume":"20","author":"Tarvasmaki","year":"2016","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.jcrc.2019.04.029_bb0370","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s001340050329","article-title":"Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study","volume":"23","author":"Levy","year":"1997","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.jcrc.2019.04.029_bb0375","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2019.04.029_bb0380","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13063-014-0541-9","article-title":"Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial","volume":"16","author":"Harris","year":"2015","journal-title":"Trials"},{"issue":"7","key":"10.1016\/j.jcrc.2019.04.029_bb0385","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1128\/AAC.00365-16","article-title":"A multinational, preregistered cohort study of beta-lactam\/beta-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-Spectrum-beta-lactamase-producing Enterobacteriaceae","volume":"60","author":"Gutierrez-Gutierrez","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.jcrc.2019.04.029_bb0390","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/cix606","article-title":"Empiric therapy with Carbapenem-sparing regimens for bloodstream infections due to extended-Spectrum beta-lactamase-producing Enterobacteriaceae: results from the INCREMENT cohort","volume":"65","author":"Palacios-Baena","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jcrc.2019.04.029_bb0395","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systematic review and meta-analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jcrc.2019.04.029_bb0400","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ijantimicag.2019.03.007","article-title":"Post-MERINO trial: any role for piperacillin-tazobactam in treating bloodstream infections caused by extended-spectrum beta-lactamase producing Enterobacteriaceae?","volume":"53","author":"Sfeir","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.jcrc.2019.04.029_bb0405","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/jama.2018.19345","article-title":"Antibiotics for ceftriaxone-resistant gram-negative bacterial bloodstream infections","volume":"321","author":"Rodriguez-Bano","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2019.04.029_bb0410","unstructured":"@jesusrbano. \"Thanks @padstamundo Important to understand Merino results. Would need a reevaluation with only really susceptible isolates - raised in our letter here: https:\/\/jamanetwork.com\/journals\/jama\/article-abstract\/2724182 \u2026Piptazo MIC impact on mortality of ESBLs previously shown here: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3697383\/#__ffn_sectitle.\" Twitter, 18 April 2019."}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944119300553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944119300553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:40:46Z","timestamp":1760125246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944119300553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":82,"alternative-id":["S0883944119300553"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2019.04.029","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Major publications in critical care pharmacotherapy literature in 2018","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2019.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}